Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy.

Creator(s)

Evan Cantor
Rachel Berkovich, Children's Mercy Kansas CityFollow
Pournima Navalkele
Nicole M. Brossier

Document Type

Article

Publication Date

7-2023

Identifier

DOI: 10.1002/pbc.30296

Journal Title

Pediatric blood & cancer

Volume

70

Issue

7

First Page

30296

Last Page

30296

MeSH Keywords

Humans; Ganglioglioma; Proto-Oncogene Proteins B-raf; Brain Neoplasms; Mutation

Keywords

Ganglioglioma; Proto-Oncogene Proteins B-raf; Brain Neoplasms; Mutation

Comments

Grant support

• K12 HD076224/HD/NICHD NIH HHS/United States

Recommended Citation

Cantor E, Berkovich R, Navalkele P, Brossier NM. Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy. Pediatr Blood Cancer. 2023;70(7):e30296. doi:10.1002/pbc.30296